File No. 37008/2021/Div.VI/NPPA
Government of India
Ministry of Chemicals & Fertilizers
Department of Pharmaceuticals
National Pharmaceutical Pricing Authority
3rd and 5th Floor,
YMCA Cultural Centre Building,
1, Jai Singh Road, New Delhi – 110 001
Dated: 17th April 2021
OFFICE MEMORANDUM
This is with reference to the ongoing efforts for enhancement of availability and affordability of ‘Remdesivir injection. On the intervention of the Government, the major manufacturers/marketers of ‘Remdesivir injection’ have reported voluntary reduction in Maximum Retail Price (MRP). The revised prices of major brands of ‘Remdesivir injection 100mg/Vial’ are as follows:
| S.No. | Name of the Company | Brand Name |
Earlier MRP (Rs.) |
Revised MRP |
| 1. | Cadila Healthcare Ltd | REMDAC | 2,800/- | 899/- |
| 2. | Syngene International Ltd (Biocon Biologics India) | RemWin | 3,950/- | 2,450/- |
| 3. | Dr. Reddy’s Laboratories Ltd | REDYX | 5,400/- | 2,700/- |
| 4. | Cipla Ltd | CIPREMI | 4,000/- | 3,000/- |
| 5. | Mylan Pharmaceuticals Pvt Ltd | DESREM | 4,800/- | 3,400/- |
| 6. | Jubilant Generics Ltd | JUBI-R | 4,700/- | 3,400/- |
| 7. | Hetero Healthcare Ltd | COVIFOR | 5,400/- | 3,490/- |
(Dr. Vinod Kotwal)
Member Secretary
To
Drug Controller / Food & Drug Administration of all State / UT Governments for information and compliance
Copy for information to:
- PPS to Hon’ble Minister (HCF)
- PPS to Hon’ble Minister of State (HCF)
- Secretary (Pharma), Gol
- Secretary (Health),GoI
- Pr. Health Secretaries (All States/UTs)
- Drug Controller General (India)
